Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9302683 | 0.84 | CA2 (0.40) | CA1CA2CA12CA7CA14 | |
| SCHEMBL10437267 | 0.72 | — | — | |
| SCHEMBL276258 | 0.71 | CA2 (0.50) | CA1CA2CA12CA7CA14 | |
| SCHEMBL20542290 | 0.64 | CA2 (0.50) | CA1CA2CA12CA7CA14 | |
| SCHEMBL276801 | 0.64 | CA2 (0.43) | CA1CA2CA12CA7CA14 | |
| SCHEMBL24665746 | 0.64 | CA2 (0.50) | CA1CA2CA12CA7CA14 | |
| SCHEMBL28094369 | 0.63 | — | — | |
| SCHEMBL224724 | 0.63 | — | — | |
| SCHEMBL31388279 | 0.62 | KDM4E (0.48) | CA1CA2CA12CA7CA14 | |
| 1,2-Dichloroethane SCHEMBL28978798 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2968314-A2 | NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS | Galderma Research & Development (FR) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014140861-A2 | NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2014-09-18 | — | — | WO | disclosed |